A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention

Human Molecular Genetics

Volumn 20, Issue 23, 2011, Pages 4748-4757

  Sampietro, M Lourdes ^a,j   Trompet, Stella ^a   Verschuren, Jeffrey J W ^a   Talens, Rudolf P ^a   Deelen, Joris ^a   Heijmans, Bastiaan T ^a   de Winter, Robbert J ^b   Tio, Rene A ^c   M Doevendans, Pieter A F ^d   Ganesh, Santhi K ^e   Nabel, Elizabeth G ^f   Westra, Harm Jan ^c   Franke, Lude ^c,g   van den Akker, Erik B ^a,h   Westendorp, Rudi G J ^a   Zwinderman, Aeilko H ^b   Kastrati, Adnan ⁱ   Koch, Werner ⁱ   Slagboom, P Eline ^a   de Knijff, Peter ^a   Jukema, J Wouter ^a,j,k   more..

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^k Durrer Center for Cardiogenetic Research   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHROMOSOME 12; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RESTENOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHROMOSOMES, HUMAN, PAIR 12; CORONARY RESTENOSIS; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 81255209178     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr389     Document Type: Article

References (56)

1. Agema, W.R., Monraats, P.S., Zwinderman, A.H., de Winter, R.J., Tio, R.A., Doevendans, P.A., Waltenberger, J., de Maat, M.P., Frants, R.R., Atsma, D.E. et al. (2004) Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era. Eur. Heart. J., 25, 1163-1170.
2. Roiron, C., Sanchez, P., Bouzamondo, A., Lechat, P. and Montalescot, G. (2006) Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart, 92, 641-649.
3. Sigwart, U., Puel, J., Mirkovitch, V., Joffre, F. and Kappenberger, L. (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N. Engl. J. Med., 316, 701-706.
4. Lee, M.S., David, E.M., Makkar, R.R. and Wilentz, J.R. (2004) Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J. Pathol., 203, 861-870.
5. Pache, J., Kastrati, A., Mehilli, J., Schuhlen, H., Dotzer, F., Hausleiter, J., Fleckenstein, M., Neumann, F.J., Sattelberger, U., Schmitt, C. et al. (2003) Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J. Am. Coll. Cardiol., 41, 1283-1288.
6. Serruys, P.W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V. and Materne, P. (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N. Engl. J. Med., 331, 489-495.
7. Ross, R., Masuda, J. and Raines, E.W. (1990) Cellular interactions, growth factors, and smooth muscle proliferation in atherogenesis. Ann. N. Y. Acad. Sci., 598, 102-112.
8. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med., 340, 115-126.
9. Rajagopal, V. and Rockson, S.G. (2003) Coronary restenosis: a review of mechanisms and management. Am. J. Med., 115, 547-553.
10. Arjomand, H., Turi, Z.G., McCormick, D. and Goldberg, S. (2003) Percutaneous coronary intervention: historical perspectives, current status, and future directions. Am. Heart. J., 146, 787-796.
11. Jenkins, N.P., Prendergast, B.D. and Thomas, M. (2002) Drug eluting coronary stents. BMJ, 325, 1315-1316.
12. Morice, M.C., Serruys, P.W., Sousa, J.E., Fajadet, J., Ban, H.E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G. et al. (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med., 346, 1773-1780.
13. Stone, G.W., Ellis, S.G., O'Shaughnessy, C.D., Martin, S.L., Satler, L., McGarry, T., Turco, M.A., Kereiakes, D.J., Kelley, L., Popma, J.J. and Russell, M.E. (2006) Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA, 295, 1253-1263.
14. Bourassa, M.G., Lesperance, J., Eastwood, C., Schwartz, L., Cote, G., Kazim, F. and Hudon, G. (1991) Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol., 18, 368-376.
15. Stein, B., Weintraub, W.S., Gebhart, S.P., Cohen-Bernstein, C.L., Grosswald, R., Liberman, H.A., Douglas, J.S. Jr, Morris, D.C. and King, S.B. III (1995) Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation, 91, 979-989.
16. Agema, W.R., Jukema, J.W., Pimstone, S.N. and Kastelein, J.J. (2001) Genetic aspects of restenosis after percutaneous coronary interventions: towards more tailored therapy. Eur. Heart. J., 22, 2058-2074.
17. Kastrati, A., Schomig, A., Elezi, S., Schuhlen, H., Wilhelm, M. and Dirschinger, J. (1998) Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions. Circulation, 97, 2396-2401.
18. de Maat, M.P., Jukema, J.W., Ye, S., Zwinderman, A.H., Moghaddam, P.H., Beekman, M., Kastelein, J.J., van Boven, A.J., Bruschke, A.V., Humphries, S.E. et al. (1999) Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am. J. Cardiol., 83, 852-856.
19. Kastrati, A., Schomig, A., Seyfarth, M., Koch, W., Elezi, S., Bottiger, C., Mehilli, J., Schomig, K. and von Beckerath, N. (1999) PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation, 99, 1005-1010.
20. Monraats, P.S., Pires, N.M., Agema, W.R., Zwinderman, A.H., Schepers, A., de Maat, M.P., Doevendans, P.A., de Winter, R.J., Tio, R.A., Waltenberger, J. et al. (2005) Genetic inflammatory factors predict restenosis after percutaneous coronary interventions. Circulation, 112, 2417-2425.
21. Monraats, P.S., Pires, N.M., Schepers, A., Agema, W.R., Boesten, L.S., De Vries, M.R., Zwinderman, A.H., de Maat, M.P., Doevendans, P.A., de Winter, R.J. et al. (2005) Tumor necrosis factor-alpha plays an important role in restenosis development. FASEB J., 19, 1998-2004.
22. Amant, C., Bauters, C., Bodart, J.C., Lablanche, J.M., Grollier, G., Danchin, N., Hamon, M., Richard, F., Helbecque, N., McFadden, E.P. et al. (1997) D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation, 96, 56-60.
23. Koch, W., Kastrati, A., Mehilli, J., Bottiger, C., von Beckerath, N. and Schomig, A. (2000) Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation, 102, 197-202.
24. Agema, W.R., Jukema, J.W., Zwinderman, A.H. and van der Wall, E.E. (2002) A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias. Am. Heart J., 144, 760-768.
25. Higgins, J.P., Thompson, S.G., Deeks, J.J. and Altman, D.G. (2003) Measuring inconsistency in meta-analyses. BMJ, 327, 557-560.
26. MacIntyre, G., Bailey, J., Haviv, I. and Kowalczyk, A. (2010) is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics, 26, i524-i530.
27. Blastyak, A., Hajdu, I., Unk, I. and Haracska, L. (2010) Role of double-stranded DNA translocase activity of human HLTF in replication of damaged DNA. Mol. Cell Biol., 30, 684-693.
28. Hata, S., Hamada, J., Maeda, K., Murai, T., Tada, M., Furukawa, H., Tsutsumida, A., Saito, A., Yamamoto, Y. and Moriuchi, T. (2008) PAX4 has the potential to function as a tumor suppressor in human melanoma. Int. J. Oncol., 33, 1065-1071.
29. Gallo, R., Padurean, A., Jayaraman, T., Marx, S., Roque, M., Adelman, S., Chesebro, J., Fallon, J., Fuster, V., Marks, A. and Badimon, J.J. (1999) Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation, 99, 2164-2170.
30. Giannakakou, P., Robey, R., Fojo, T. and Blagosklonny, M.V. (2001) Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/ G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene, 20, 3806-3813.
31. Argiropoulos, B. and Humphries, R.K. (2007) Hox genes in hematopoiesis and leukemogenesis. Oncogene, 26, 6766-6776.
32. Dubois, P.C., Trynka, G., Franke, L., Hunt, K.A., Romanos, J., Curtotti, A., Zhernakova, A., Heap, G.A., Adany, R., Aromaa, A. et al. (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet., 42, 295-302.
33. Lee, S.J., So, I.S., Park, S.Y. and Kim, I.S. (2008) Thymosin beta4 is involved in stabilin-2-mediated apoptotic cell engulfment. FEBS Lett., 582, 2161-2166.
34. Park, S.Y., Kim, S.Y., Jung, M.Y., Bae, D.J. and Kim, I.S. (2008) Epidermal growth factor-like domain repeat of stabilin-2 recognizes phosphatidylserine during cell corpse clearance. Mol. Cell Biol., 28, 5288-5298.
35. Harris, E.N., Baggenstoss, B.A. and Weigel, P.H. (2009) Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins. Am. J. Physiol. Gastrointest. Liver Physiol., 296, G1191-G1199.
36. Yatsuoka, T., Furukawa, T., Sunamura, M., Matsuno, S. and Horii, A. (2004) TU12B1-TY, a novel gene in the region at 12q22-q23.1 frequently deleted in pancreatic cancer, shows reduced expression in pancreatic cancer cells. Oncol. Rep., 12, 1263-1268.
37. Sabo, P.J., Hawrylycz, M., Wallace, J.C., Humbert, R., Yu, M., Shafer, A., Kawamoto, J., Hall, R., Mack, J., Dorschner, M.O. et al. (2004) Discovery of functional noncoding elements by digital analysis of chromatin structure. Proc. Natl Acad. Sci. USA, 101, 16837-16842.
38. Sabo, P.J., Humbert, R., Hawrylycz, M., Wallace, J.C., Dorschner, M.O., McArthur, M. and Stamatoyannopoulos, J.A. (2004) Genome-wide identification of DNaseI hypersensitive sites using active chromatin sequence libraries. Proc. Natl Acad. Sci. USA, 101, 4537-4542.
39. Knudsen, S. (1999) Promoter2.0: for the recognition of PolII promoter sequences. Bioinformatics, 15, 356-361.
40. Visel, A., Zhu, Y., May, D., Afzal, V., Gong, E., Attanasio, C., Blow, M.J., Cohen, J.C., Rubin, E.M. and Pennacchio, L.A. (2010) Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature, 464, 409-412.
41. Hardy, J. and Singleton, A. (2009) Genomewide association studies and human disease. N. Engl. J. Med., 360, 1759-1768.
42. Teslovich, T.M., Musunuru, K., Smith, A.V., Edmondson, A.C., Stylianou, I.M., Koseki, M., Pirruccello, J.P., Ripatti, S., Chasman, D.I., Willer, C.J. et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466, 707-713.
43. Gerrits, A., Li, Y., Tesson, B.M., Bystrykh, L.V., Weersing, E., Ausema, A., Dontje, B., Wang, X., Breitling, R., Jansen, R.C. and de, H.G. (2009) Expression quantitative trait loci are highly sensitive to cellular differentiation state. PLoS Genet., 5, e1000692.
44. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. and Sham, P.C. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
45. Li, J.Z., Absher, D.M., Tang, H., Southwick, A.M., Casto, A.M., Ramachandran, S., Cann, H.M., Barsh, G.S., Feldman, M., Cavalli-Sforza, L.L. and Myers, R.M. (2008) Worldwide human relationships inferred from genome-wide patterns of variation. Science, 319, 1100-1104.
46. Ganesh, S.K., Skelding, K.A., Mehta, L., O'Neill, K., Joo, J., Zheng, G., Goldstein, J., Simari, R., Billings, E., Geller, N.L. et al. (2004) Rationale and study design of the CardioGene Study: genomics of in-stent restenosis. Pharmacogenomics, 5, 952-1004.
47. Aulchenko, Y.S., Struchalin, M.V. and van Duijn, C.M. (2010) ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics, 11, 134.
48. Hoppmann, P., Erl, A., Turk, S., Tiroch, K., Mehilli, J., Schomig, A., Kastrati, A. and Koch, W. (2009) No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents. JACC Cardiovasc. Interv., 2, 1149-1155.
49. Shepherd, J., Blauw, G.J., Murphy, M.B., Cobbe, S.M., Bollen, E.L., Buckley, B.M., Ford, I., Jukema, J.W., Hyland, M., Gaw, A. et al. (1999) The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am. J. Cardiol., 84, 1192-1197.
50. Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L., Buckley, B.M., Cobbe, S.M., Ford, I., Gaw, A., Hyland, M., Jukema, J.W. et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 360, 1623-1630.
51. Aulchenko, Y.S., Ripke, S., Isaacs, A. and van Duijn, C.M. (2007) GenABEL: an R library for genome-wide association analysis. Bioinformatics, 23, 1294-1296.
52. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
53. Pruim, R.J., Welch, R.P., Sanna, S., Teslovich, T.M., Chines, P.S., Gliedt, T.P., Boehnke, M., Abecasis, G.R. and Willer, C.J. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics, 26, 2336-2337.
54. McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Goldstein, D.B., Little, J., Ioannidis, J.P. and Hirschhorn, J.N. (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet., 9, 356-369.
55. Li, Y., Willer, C., Sanna, S. and Abecasis, G. (2009) Genotype imputation. Annu. Rev. Genomics Hum. Genet., 10, 387-406.
56. Li, Y., Willer, C.J., Ding, J., Scheet, P. and Abecasis, G.R. (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol., 34, 816-834.